193 related articles for article (PubMed ID: 18365932)
1. Measuring attitudes toward injecting drug users and people with hepatitis C.
Brener L; von Hippel W
Subst Use Misuse; 2008; 43(3-4):295-302. PubMed ID: 18365932
[TBL] [Abstract][Full Text] [Related]
2. Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?
Brener L; von Hippel W; Kippax S
Int J Drug Policy; 2007 Oct; 18(5):381-7. PubMed ID: 17854726
[TBL] [Abstract][Full Text] [Related]
3. The depiction of stigmatization in research about hepatitis C.
Paterson BL; Backmund M; Hirsch G; Yim C
Int J Drug Policy; 2007 Oct; 18(5):364-73. PubMed ID: 17854724
[TBL] [Abstract][Full Text] [Related]
4. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
Hopwood M; Treloar C
Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
6. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
7. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
Wozniak L; Prakash M; Taylor M; Wild TC
Int J Drug Policy; 2007 Oct; 18(5):388-96. PubMed ID: 17854727
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
Day C; Ross J; Dolan K
Drug Alcohol Rev; 2003 Sep; 22(3):317-21. PubMed ID: 15385226
[TBL] [Abstract][Full Text] [Related]
9. The role of physician and nurse attitudes in the health care of injecting drug users.
Brener L; Von Hippel W; Kippax S; Preacher KJ
Subst Use Misuse; 2010 Jun; 45(7-8):1007-18. PubMed ID: 20441447
[TBL] [Abstract][Full Text] [Related]
10. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
[TBL] [Abstract][Full Text] [Related]
12. Injecting drug users' understanding of hepatitis C.
O'Brien S; Day C; Black E; Dolan K
Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
[TBL] [Abstract][Full Text] [Related]
13. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
Kretzschmar M; Wiessing L
AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
[TBL] [Abstract][Full Text] [Related]
14. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
Imani R; Karimi A; Rouzbahani R; Rouzbahani A
East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
[TBL] [Abstract][Full Text] [Related]
16. Modelling the hepatitis C virus epidemic in Australia.
Razali K; Thein HH; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M
Drug Alcohol Depend; 2007 Dec; 91(2-3):228-35. PubMed ID: 17669601
[TBL] [Abstract][Full Text] [Related]
17. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
Doab A; Treloar C; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
[TBL] [Abstract][Full Text] [Related]
18. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M
Addiction; 2006 Sep; 101(9):1246-53. PubMed ID: 16911723
[TBL] [Abstract][Full Text] [Related]
20. The anatomy of risk: a quantitative investigation into injection drug users' taxonomy of risk attitudes and perceptions.
Marsch LA; Bickel WK; Badger GJ; Quesnel KJ
Exp Clin Psychopharmacol; 2007 Apr; 15(2):195-203. PubMed ID: 17469943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
